NeuroOne Medical Technologies Corporation Proceeds from Debt, Net of Issuance Costs
NeuroOne Medical Technologies Corporation (NMTC) reported Proceeds from Debt, Net of Issuance Costs of $5.20 million for the 1-month period ending 2023-07-31, per its 10-K filed 2024-12-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2024-12-17
- 2023-07-31: Proceeds from Debt, Net of Issuance Costs 1 month $5.20M.
| Period end | Proceeds from Debt, Net of Issuance Costs 1 month |
|---|---|
| 2023-07-31 | $5.20M 10-K · filed 2024-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |